Llwytho...
Use of New Oral Anticoagulants / Direct Oral Anticoagulants in Malignant Patients
Vitamin K antagonists are being used in the last five decades as an effective anticoagulant. However, for the past few years, new oral anticoagulants (NOACs) have been introduced as newer anticoagulant agents, which are gradually replacing the previously used vitamin K antagonist. Yet, these agents...
Wedi'i Gadw mewn:
| Cyhoeddwyd yn: | Cureus |
|---|---|
| Prif Awduron: | , , , , |
| Fformat: | Artigo |
| Iaith: | Inglês |
| Cyhoeddwyd: |
Cureus
2020
|
| Pynciau: | |
| Mynediad Ar-lein: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7077741/ https://ncbi.nlm.nih.gov/pubmed/32206471 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7759/cureus.7007 |
| Tagiau: |
Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!
|